ORTHOMAB Trademark

Trademark Overview


On Monday, September 17, 2018, a trademark application was filed for ORTHOMAB with the United States Patent and Trademark Office. The USPTO has given the ORTHOMAB trademark a serial number of 88119859. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 1, 2021. This trademark is owned by Dualogics, LLC. The ORTHOMAB trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Biological and biochemical preparations, namely, antibodies, antibody derivatives and binding proteins for research and development purposes; biochemicals, namely, bispecific antibodies for medical and scientific research; biochemicals, namely, bispecific antibodies for in vitro scientific and research use

Therapeutic pharmaceuticals in the nature of biological and biochemical preparations, namely, antibodies, antibody derivatives and binding proteins for treatment of diseases, namely, cardiovascular, endocrinological, metabolic, musculoskeletal, neurological, and respiratory diseases, cancer, genetic rare diseases, autoimmune diseases and immunological conditions

Research and development services in the field of antibodies
orthomab

General Information


Serial Number88119859
Word MarkORTHOMAB
Filing DateMonday, September 17, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 1, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 6, 2019

Trademark Statements


Goods and ServicesBiological and biochemical preparations, namely, antibodies, antibody derivatives and binding proteins for research and development purposes; biochemicals, namely, bispecific antibodies for medical and scientific research; biochemicals, namely, bispecific antibodies for in vitro scientific and research use
Goods and ServicesTherapeutic pharmaceuticals in the nature of biological and biochemical preparations, namely, antibodies, antibody derivatives and binding proteins for treatment of diseases, namely, cardiovascular, endocrinological, metabolic, musculoskeletal, neurological, and respiratory diseases, cancer, genetic rare diseases, autoimmune diseases and immunological conditions
Goods and ServicesResearch and development services in the field of antibodies

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateSunday, September 23, 2018
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, September 23, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, September 23, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAbCellera Biologics Inc.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressVancouver, British Columbia V5Y0A1
CA

Party NameDualogics, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDurham, NC 27713

Party NameDualogics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDurham, NC 27713

Trademark Events


Event DateEvent Description
Monday, November 1, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 1, 2021ABANDONMENT - NO USE STATEMENT FILED
Wednesday, July 28, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 28, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 28, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 14, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 13, 2021EXTENSION 3 GRANTED
Wednesday, March 31, 2021EXTENSION 3 FILED
Tuesday, April 13, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 7, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, March 31, 2021TEAS EXTENSION RECEIVED
Tuesday, October 20, 2020ASSIGNED TO EXAMINER
Thursday, October 1, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 29, 2020EXTENSION 2 GRANTED
Tuesday, September 29, 2020EXTENSION 2 FILED
Tuesday, September 29, 2020TEAS EXTENSION RECEIVED
Saturday, March 28, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 26, 2020EXTENSION 1 GRANTED
Thursday, March 26, 2020EXTENSION 1 FILED
Thursday, March 26, 2020TEAS EXTENSION RECEIVED
Tuesday, October 1, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 6, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 6, 2019PUBLISHED FOR OPPOSITION
Wednesday, July 17, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 3, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 3, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 3, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 3, 2019ASSIGNED TO LIE
Friday, June 28, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 28, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 28, 2018NON-FINAL ACTION E-MAILED
Friday, December 28, 2018NON-FINAL ACTION WRITTEN
Friday, December 28, 2018ASSIGNED TO EXAMINER
Sunday, September 23, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 20, 2018NEW APPLICATION ENTERED IN TRAM